| abstract |
The invention relates to a 4,4-disubstituted-3,4-dihydro-2-(1H)-quinazolinone compound as well as a synthetic method and use thereof. The compound is a compound with a following structure formula, or a stereoismeric form, a stereisomer mixture or a pharmaceutically acceptable salt, wherein the structure formula is as shown in the specification. The compound is simple and convenient in synthetic method, and can be used as an efficient human immunodeficiency virus-1 (HIV-1) reverse transcriptase inhibitor. |